|
EP1005484A1
(en)
*
|
1997-06-20 |
2000-06-07 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
US6127341A
(en)
*
|
1997-06-20 |
2000-10-03 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
PL194560B1
(pl)
*
|
1998-05-11 |
2007-06-29 |
Novo Nordisk As |
Związki o właściwościach uwalniania hormonu wzrostu, kompozycja farmaceutyczna zawierająca te związki oraz ich zastosowanie
|
|
TW450954B
(en)
*
|
1998-05-14 |
2001-08-21 |
Pharmacia & Amp Upjohn Company |
Phenylsulfonamide-phenylethylamines useful as dopamine receptors
|
|
US6919315B1
(en)
|
1998-06-30 |
2005-07-19 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
|
AU771644B2
(en)
*
|
1998-06-30 |
2004-04-01 |
Helsinn Healthcare Sa |
Compounds with growth hormone releasing properties
|
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
|
CN1157224C
(zh)
|
1999-02-18 |
2004-07-14 |
科研制药株式会社 |
用作生长激素促分泌剂的新酰胺衍生物
|
|
UA73530C2
(uk)
*
|
1999-11-10 |
2005-08-15 |
Ново Нордіск А/С |
Сполука з властивостями вивільнювати гормон росту
|
|
US6992081B2
(en)
|
2000-03-23 |
2006-01-31 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
|
US6737420B2
(en)
*
|
2000-03-23 |
2004-05-18 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
|
US7423177B2
(en)
*
|
2001-03-05 |
2008-09-09 |
Transtech Pharma, Inc. |
Carboxamide derivatives as therapeutic agents
|
|
US6613801B2
(en)
*
|
2000-05-30 |
2003-09-02 |
Transtech Pharma, Inc. |
Method for the synthesis of compounds of formula I and their uses thereof
|
|
EP1159964B1
(en)
|
2000-05-31 |
2009-10-28 |
Pfizer Products Inc. |
Use of growth hormone secretagogues for stimulating gastrointestinal motility
|
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
|
CA2410680A1
(en)
|
2000-06-30 |
2002-01-10 |
Elan Pharmaceuticals, Inc. |
Compounds to treat alzheimer's disease
|
|
EP1666452A2
(en)
|
2000-06-30 |
2006-06-07 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
|
US20030096864A1
(en)
*
|
2000-06-30 |
2003-05-22 |
Fang Lawrence Y. |
Compounds to treat alzheimer's disease
|
|
US6846813B2
(en)
*
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
|
DE60211866T2
(de)
*
|
2001-02-16 |
2007-06-14 |
Allelix Neuroscience Inc. |
Thiophen substituierte amin derivate als glyt-1 inhibitoren
|
|
JP2004523565A
(ja)
*
|
2001-03-05 |
2004-08-05 |
トランス テック ファーマ，インコーポレイテッド |
治療因子としてのベンゾイミダゾール誘導体
|
|
CA2452039A1
(en)
*
|
2001-06-27 |
2003-01-09 |
Elan Pharmaceuticals, Inc. |
Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease
|
|
US20070213407A1
(en)
*
|
2001-06-29 |
2007-09-13 |
Elan Pharmaceuticals And Pharmacia & Upjohn Company Llc |
Compounds to treat Alzheimer's disease
|
|
EP1471054B1
(en)
*
|
2002-01-11 |
2009-07-01 |
Daiichi Sankyo Company, Limited |
Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
|
|
US7230133B2
(en)
|
2003-05-01 |
2007-06-12 |
Bristol-Myers Squibb Company |
Malonamides and malonamide derivatives as modulators of chemokine receptor activity
|
|
MXPA05012350A
(es)
*
|
2003-05-20 |
2006-05-25 |
Transtech Pharma Inc |
Antagonistas rage como agentes para la amiloidosis inversa y enfermedades asociadas con la misma.
|
|
US7476653B2
(en)
|
2003-06-18 |
2009-01-13 |
Tranzyme Pharma, Inc. |
Macrocyclic modulators of the ghrelin receptor
|
|
WO2005027913A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
|
|
NZ549162A
(en)
|
2004-02-24 |
2009-12-24 |
Sankyo Co |
Amino-pyrrol alcohol compounds
|
|
EP1735055A1
(en)
*
|
2004-03-30 |
2006-12-27 |
Sapphire Therapeutics, Inc. |
Method of reducing c-reactive protein using growth hormone secretagogues
|
|
MXPA06015003A
(es)
*
|
2004-06-29 |
2007-08-07 |
Sapphire Therapeutics Inc |
Formas cristalinas de 1,2,2-trimetilhidrazida de acido (3r)-1-(2-metilalanil-d-triptofil)-3-(fenilmetil)-3- piperidincarboxilico.
|
|
AU2005272598B2
(en)
*
|
2004-08-12 |
2011-11-17 |
Helsinn Therapeutics (U.S.), Inc. |
Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues
|
|
WO2007023948A1
(ja)
|
2005-08-25 |
2007-03-01 |
Ube Industries, Ltd. |
光学活性（Ｓ又はＲ）－α－アミノ酸及び光学活性（Ｒ又はＳ）－α－アミノ酸エステルの製造方法
|
|
CU23558A1
(es)
|
2006-02-28 |
2010-07-20 |
Ct Ingenieria Genetica Biotech |
Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
|
|
US8889632B2
(en)
|
2007-01-31 |
2014-11-18 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
|
US9371297B2
(en)
|
2007-02-09 |
2016-06-21 |
Ocera Therapeutics, Inc. |
Macrocyclic ghrelin receptor modulators and methods of using the same
|
|
KR20090112720A
(ko)
*
|
2007-02-13 |
2009-10-28 |
헬신 세라퓨틱스 (유.에스.) 인크. |
성장 호르몬 분비촉진제를 이용한 세포 증식 질환의 치료방법
|
|
EP2508531B1
(en)
|
2007-03-28 |
2016-10-19 |
President and Fellows of Harvard College |
Stitched polypeptides
|
|
TWI429436B
(zh)
*
|
2007-04-10 |
2014-03-11 |
Helsinn Therapeutics Us Inc |
使用生長激素促泌素治療或預防嘔吐之方法
|
|
UA105657C2
(uk)
|
2009-02-27 |
2014-06-10 |
Хелсінн Терапьютікс (Ю.Ес.), Інк. |
Поліпшені способи лікування мігрені на основі анамореліну
|
|
WO2011041198A1
(en)
|
2009-09-30 |
2011-04-07 |
Transtech Pharma, Inc. |
Substituted imidazole derivatives for treatment of alzheimers disease
|
|
RU2016111360A
(ru)
|
2010-08-13 |
2018-11-27 |
Эйлерон Терапьютикс, Инк. |
Пептидомиметические макроциклы
|
|
CN108929375A
(zh)
|
2011-10-18 |
2018-12-04 |
爱勒让治疗公司 |
拟肽大环化合物
|
|
HK1205454A1
(en)
|
2012-02-15 |
2015-12-18 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
RU2017145921A
(ru)
|
2012-02-15 |
2019-02-21 |
Эйлерон Терапьютикс, Инк. |
Пептидомиметические макроциклы
|
|
US9717710B2
(en)
|
2012-10-05 |
2017-08-01 |
Vtv Therapeutics Llc |
Treatment of mild and moderate Alzheimer's disease
|
|
CN104812384B
(zh)
|
2012-11-01 |
2020-09-18 |
爱勒让治疗公司 |
二取代的氨基酸及其制备和使用方法
|
|
US9119832B2
(en)
|
2014-02-05 |
2015-09-01 |
The Regents Of The University Of California |
Methods of treating mild brain injury
|
|
JP2017533889A
(ja)
|
2014-09-24 |
2017-11-16 |
エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
ペプチド模倣大環状分子およびその使用
|
|
US10253067B2
(en)
|
2015-03-20 |
2019-04-09 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
WO2017075535A1
(en)
|
2015-10-28 |
2017-05-04 |
Oxeia Biopharmaceuticals, Inc. |
Methods of treating neurodegenerative conditions
|
|
EP3916817B1
(en)
|
2016-02-09 |
2024-09-18 |
Lumeova, Inc |
Ultra-wideband, wireless optical high speed communication devices and systems
|
|
WO2019190822A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
WO2019190823A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chlorophenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
EP3864008A1
(en)
|
2018-10-10 |
2021-08-18 |
vTv Therapeutics LLC |
Metabolites of [3-(4-{2-butyl-l-[4-(4-chloro-phenoxy)-phenyl]-lh-imidazol-4-yl } -phen ox y)-prop yl] -diethyl-amine
|